Phibro Animal Health Corporatio

Historical 13F Holders

Symbol
PAHC
CUSIP
71742Q106
All holders as of
Q2 2026
Type
Equity
Class
CL A COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 71742Q106 since 12/18/2024, newest first.

Filer % of Class Filed
FMR LLC 13G/A Amendment 1
15.0% 8/6/2026
Event 6/30/2026
Millennium Management LLC 13G
5.1% 7/30/2026
Event 7/23/2026
BFI Co., LLC 13D/A Amendment 25
48.2% 5/22/2026
Event 5/20/2026
Barclays PLC 13G/A Amendment 1 1.3% 5/14/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.1% 4/30/2026
Event 3/31/2026
BFI Co., LLC 13D/A Amendment 24
48.3% 4/23/2026
Event 4/21/2026
FMR LLC 13G
10.5% 4/7/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 13 0% 3/27/2026
Event 3/13/2026
Barclays PLC 13G 5.1% 2/11/2026
Event 12/31/2025
BFI Co., LLC 13D/A Amendment 23
49.3% 12/15/2025
Event 12/11/2025
BFI Co., LLC 13D/A Amendment 22
49.9% 6/3/2025
Event 5/30/2025
BlackRock, Inc. 13G/A Amendment 4 15.7% 4/28/2025
Event 3/31/2025
Pzena Investment Management LLC 13G/A Amendment 1 3.6% 4/28/2025
Event 3/31/2025
Brandes Investment Partners, L.P. 13G/A Amendment 2
3.3% 2/14/2025
Event 12/31/2024
Brandes Investment Partners, L.P. 13G/A Amendment 1
10.5%
Checked 5% or less
2/14/2025
Event 12/31/2024
Pzena Investment Management LLC 13G 7.2% 10/16/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 2.23 k $79.8 k
2026 Q2 214 21.9 M $689 M
2026 Q1 263 20.4 M $1.12 B
2025 Q4 234 19.4 M $723 M
2025 Q3 223 19.9 M $803 M
2025 Q2 200 20.5 M $523 M
2025 Q1 187 20.3 M $434 M
2024 Q4 177 20.8 M $437 M
2024 Q3 150 20.4 M $459 M
2024 Q2 149 20.6 M $346 M
2024 Q1 144 21.4 M $277 M
2023 Q4 142 21.2 M $245 M
2023 Q3 127 20.1 M $257 M
2023 Q2 135 20.3 M $274 M
2023 Q1 136 20.3 M $311 M
2022 Q4 138 20.9 M $280 M
2022 Q3 152 19.9 M $265 M
2022 Q2 148 20.7 M $395 M
2022 Q1 153 20.5 M $409 M
2021 Q4 145 20.3 M $415 M
2021 Q3 142 20.4 M $440 M
2021 Q2 147 21.3 M $615 M
2021 Q1 144 22.5 M $573 M
2020 Q4 139 20.9 M $406 M
2020 Q3 142 20.7 M $360 M
2020 Q2 159 44.7 M $1.14 B
2020 Q1 159 20.6 M $497 M
2019 Q4 159 21.1 M $524 M
2019 Q3 155 20.7 M $441 M
2019 Q2 177 21.1 M $671 M
2019 Q1 181 20.5 M $676 M
2018 Q4 194 20.5 M $659 M
2018 Q3 201 20.8 M $894 M
2018 Q2 176 19.7 M $905 M
2018 Q1 173 19.7 M $781 M
2017 Q4 170 19.3 M $646 M
2017 Q3 166 19.4 M $720 M
2017 Q2 169 19.1 M $707 M
2017 Q1 156 18.8 M $528 M
2016 Q4 144 18.6 M $546 M
2016 Q3 124 18.6 M $506 M
2016 Q2 127 18.9 M $353 M
2016 Q1 125 19.2 M $521 M
2015 Q4 127 20.0 M $603 M
2015 Q3 127 18.9 M $597 M
2015 Q2 122 17.8 M $695 M
2015 Q1 110 17.3 M $614 M
2014 Q4 93 17.6 M $555 M
2014 Q3 73 17.5 M $391 M
2014 Q2 66 14.6 M $320 M